Add Yahoo as a preferred source to see more of our stories on Google. Whether you suffer from psoriasis yourself or have heard about it from a famous Kardashian who has been very transparent about her ...

By Sneha S K April 27 (Reuters) - Oruka Therapeutics said on Monday that interim results showed its experimental drug helped clear psoriasis within 16 weeks, meeting the main goal of a mid-stage study ...

A long-acting injectable treatment for plaque psoriasis helped 63% of patients achieve complete skin clearance in a clinical ...

Oruka Therapeutics shares gained after the company announced positive results for its Phase 2a trial of a psoriasis treatment. The stock jumped 22% to $84 in premarket trading Monday. Through Friday's ...

European regulators have recommended expanding use of the IL-23 inhibitor Skyrizi to treat moderate-to-severe plaque psoriasis in children aged 6 years or older who require systemic therapy.

Switching to guselkumab for psoriasis treatment was associated with the greatest rate of treatment persistence when compared with other therapies.

Measures of skin discoloration had a greater effect on quality of life in patients with psoriasis than overall clearance of skin lesions.

PA2G4 drives keratinocyte growth in psoriasis, highlighting a promising new treatment target. Find out more about this ...

Plaque psoriasis is a long-lasting skin condition that causes thick, scaly patches (plaques) on the skin. It happens when your immune system becomes overactive and speeds up the growth of skin cells.

Please provide your email address to receive an email when new articles are posted on . Both vaccinated and post-infection patients with psoriasis were included in this study. Researchers found that ...